D. Kirkpatrick

D. Kirkpatrick

Verkställande Direktör på ENSYSCE BIOSCIENCES, INC.

Förmögenhet: 30 $ per 2026-05-31

69 år
Health Technology
Consumer Services
Health Services

Profil

D.
Lynn Kirkpatrick
was the founder of ProlX Pharmaceuticals Corp., founded in 1999, serving as President & Chief Executive Officer from 1999 to 2006.
Dr. Kirkpatrick is the founder of Phusis Therapeutics, Inc., founded in 2009.
Dr. Kirkpatrick currently holds the position of President, Chief Executive Officer & Director at Ensysce Biosciences, Inc., starting in 2009.
Former positions include President, Chief Executive Officer & Director at Ensysce Biosciences, Inc., Director at BiologicsMD, Inc., Chief Scientific Officer at Biomira, Inc., Professor at the University of Regina from 1983 to 2001, and Chief Scientific Officer at Cascadian Therapeutics LLC from 2006 to 2008.
Education includes undergraduate and doctorate degrees from the University of Saskatchewan.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2025-11-13 107 ( 0 % ) 30 $ 2026-05-31

Aktiva positioner av D. Kirkpatrick

FöretagPositionStart
ENSYSCE BIOSCIENCES, INC. Verkställande Direktör 2009-01-01

Tidigare kända positioner av D. Kirkpatrick

FöretagPositionSlut
CASCADIAN THERAPEUTICS INC (USA) Teknisk/Vetenskaplig/F&U Direktör 2008-12-31
Teknisk/Vetenskaplig/F&U Direktör 2007-12-11
Verkställande Direktör 2006-01-01
Företagsledare/Principal 2001-01-01
Grundare -
Se detaljerna i D. Kirkpatricks erfarenhet

D. Kirkpatricks utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

47

Första gradens relationer

9

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag9

Health Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Distribution Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. D. Kirkpatrick